Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer.

Conclusion: Focal salvage HDR brachytherapy may provide good biochemical control with a low risk of severe toxicity. Further evaluation within clinical trials are needed to establish its role in the management of locally recurrent prostate cancer.
PMID: 32368626 [PubMed]

Source: Clinical Prostate Cancer - May 7, 2020 Category: Cancer & Oncology Authors: Slevin F, Hodgson S, Rodda SL, Bownes P, Bottomley D, Adiotomre E, Al-Qaisieh B, Dugdale E, Hulson O, Mason J, Smith J, Henry AM Tags: Clin Transl Radiat Oncol Source Type: research